Correlation Between Chromadex Corp and Acrivon Therapeutics,

Can any of the company-specific risk be diversified away by investing in both Chromadex Corp and Acrivon Therapeutics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Chromadex Corp and Acrivon Therapeutics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Chromadex Corp and Acrivon Therapeutics, Common, you can compare the effects of market volatilities on Chromadex Corp and Acrivon Therapeutics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Chromadex Corp with a short position of Acrivon Therapeutics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Chromadex Corp and Acrivon Therapeutics,.

Diversification Opportunities for Chromadex Corp and Acrivon Therapeutics,

-0.28

Correlation Coefficient

Chromadex Corp  Acrivon Therapeutics,

Very good diversification

The 3 months correlation between Chromadex and Acrivon is -0.28. Overlapping area represents the amount of risk that can be diversified away by holding Chromadex Corp and Acrivon Therapeutics, Common in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Acrivon Therapeutics, and Chromadex Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Chromadex Corp are associated (or correlated) with Acrivon Therapeutics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Acrivon Therapeutics, has no effect on the direction of Chromadex Corp i.e., Chromadex Corp and Acrivon Therapeutics, go up and down completely randomly.

Pair Corralation between Chromadex Corp and Acrivon Therapeutics,

Given the investment horizon of 90 days Chromadex Corp is expected to generate 2.2 times more return on investment than Acrivon Therapeutics,. However, Chromadex Corp is 2.2 times more volatile than Acrivon Therapeutics, Common. It trades about 0.17 of its potential returns per unit of risk. Acrivon Therapeutics, Common is currently generating about -0.07 per unit of risk. If you would invest  345.00  in Chromadex Corp on August 30, 2024 and sell it today you would earn a total of  419.00  from holding Chromadex Corp or generate 121.45% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Insignificant
Accuracy	98.44%
Values	Daily Returns

Chromadex Corp  vs.  Acrivon Therapeutics, Common

Chromadex Corp

Risk-Adjusted Performance

13 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Chromadex Corp are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Chromadex Corp exhibited solid returns over the last few months and may actually be approaching a breakup point.

Acrivon Therapeutics,

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Acrivon Therapeutics, Common has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Chromadex Corp and Acrivon Therapeutics,

The main advantage of trading using opposite Chromadex Corp and Acrivon Therapeutics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Chromadex Corp position performs unexpectedly, Acrivon Therapeutics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Acrivon Therapeutics, will offset losses from the drop in Acrivon Therapeutics,'s long position.

The idea behind Chromadex Corp and Acrivon Therapeutics, Common pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.